COSCIENS Biopharma (CSCI) had the highest return between December 19, 2023 and January 7, 2024 by a US stock, returning 3,180.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
COSCIENS Biopharma (CSCI) | 12/19/2023 - 1/7/2024 | 3,180.86% |
Celularity (CELUW) | 12/19/2023 - 1/7/2024 | 971.11% |
Mobix Labs (MOBXW) | 12/19/2023 - 1/7/2024 | 499.6% |
Swvl (SWVL) | 12/19/2023 - 1/7/2024 | 230.77% |
MMTEC (MTC) | 12/19/2023 - 1/7/2024 | 213.33% |
Sidus Space (SIDU) | 12/19/2023 - 1/7/2024 | 210.48% |
Versus Systems (VSSYW) | 12/19/2023 - 1/7/2024 | 200% |
P3 Health Partners (PIIIW) | 12/19/2023 - 1/7/2024 | 199.43% |
Cingulate (CING) | 12/19/2023 - 1/7/2024 | 172.84% |
Vince (VNCE) | 12/19/2023 - 1/7/2024 | 168% |
Cytokinetics (CYTK) | 12/19/2023 - 1/7/2024 | 156.79% |
Mawson Infrastructure (MIGI) | 12/19/2023 - 1/7/2024 | 155.12% |
Hongli Group Inc Ordinary Shares (HLP) | 12/19/2023 - 1/7/2024 | 154.29% |
Wheels Up Experience (UP) | 12/19/2023 - 1/7/2024 | 154.12% |
Syntec Optics (OPTXW) | 12/19/2023 - 1/7/2024 | 153.73% |
Alaunos Therapeutics (TCRT) | 12/19/2023 - 1/7/2024 | 147.17% |
Enlivex Therapeutics (ENLV) | 12/19/2023 - 1/7/2024 | 142.95% |
Perspective Therapeutics (CATX) | 12/19/2023 - 1/7/2024 | 138.46% |
RenovoRx (RNXT) | 12/19/2023 - 1/7/2024 | 129.14% |
QXO (QXO) | 12/19/2023 - 1/7/2024 | 125.44% |
Lottery (SEGG) | 12/19/2023 - 1/7/2024 | 123.57% |
KORE (KORE) | 12/19/2023 - 1/7/2024 | 121.15% |
Alarum Technologies (ALAR) | 12/19/2023 - 1/7/2024 | 118.68% |
Aurora Mobile (JG) | 12/19/2023 - 1/7/2024 | 117.46% |
BuzzFeed (BZFDW) | 12/19/2023 - 1/7/2024 | 115.94% |
